Vascularized bone marrow-based immunosuppression inhibits rejection of vascularized composite allografts in nonhuman primates

American Journal of Transplantation

Volumn 11, Issue 7, 2011, Pages 1407-1416

  Barth, R N ^a   Rodriguez, E D ^b   Mundinger, G S ^b   Nam, A J ^b   Ha, J S ^a   Hui Chou, H ^b   Jones, L S ^a   Panda, A ^c   Shipley, S T ^c   Drachenberg, C B ^d   Kukuruga, D ^d   Bartlett, S T ^a  

^a Division of Transplantation   (United States)

^b Division of Plastic Reconstructive and Maxillofacial Surgery   (United States)

^c Department of Surgery   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Bone marrow; chimerism; composite tissue allograft; nonhuman primate; rejection; tolerance

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ACUTE GRAFT REJECTION; ALLOGRAFT; ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CHRONIC GRAFT REJECTION; COMPOSITE GRAFT; CONTROLLED STUDY; FACIAL TRANSPLANTATION; FEMALE; GRAFT FAILURE; IMMUNE DEFICIENCY; IMMUNOMODULATION; MALE; MICROCHIMERISM; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TISSUE TRANSPLANTATION;

ABDOMINAL WALL; ANIMALS; BONE MARROW; FACIAL TRANSPLANTATION; FEMALE; GRAFT SURVIVAL; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; MACACA FASCICULARIS; MALE; MYCOPHENOLIC ACID; TACROLIMUS; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

EID: 79959832597     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03551.x     Document Type: Article

References (29)

1. Kawai T, Cosimi AB, Spitzer TR, et al,. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008; 358: 353-361. (Pubitemid 351159234)
2. Scandling JD, Busque S, jbakhsh-Jones S, et al,. Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med 2008; 358: 362-368. (Pubitemid 351159235)
3. Dubernard JM, Owen E, Herzberg G, et al,. Human hand allograft: Report on first 6 months. Lancet 1999; 353: 1315-1320. (Pubitemid 29178782)
4. Dubernard JM, Lengele B, Morelon E, et al,. Outcomes 18 months after the first human partial face transplantation. N Engl J Med 2007; 357: 2451-2460. (Pubitemid 350272784)
5. Jones JW, Gruber SA, Barker JH, Breidenbach WC,. Successful hand transplantation. One-year follow-up. Louisville Hand Transplant Team. N Engl J Med 2000; 343: 468-473. (Pubitemid 30646486)
6. Schneeberger S, Ninkovic M, Piza-Katzer H, et al,. Status 5 years after bilateral hand transplantation. Am J Transplant 2006; 6: 834-841. (Pubitemid 43345022)
7. International Registry on Hand and Composite Tissue Transplantation. 2010.
8. Ortiz J, Palma-Vargas J, Wright F, et al,. Campath induction for kidney transplantation: Report of 297 cases. Transplantation 2008; 85: 1550-1556.
9. Brennan DC, Daller JA, Lake KD, Cibrik D, Del CD,. Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med 2006; 355: 1967-1977. (Pubitemid 44708016)
10. Barth RN, Nam AJ, Stanwix MG, et al,. Prolonged survival of composite facial allografts in non-human primates associated with posttransplant lymphoproliferative disorder. Transplantation 2009; 88: 1242-1250.
11. Barth RN, Bluebond-Langner R, Nam A, et al,. Facial subunit composite tissue allografts in nonhuman primates: I. Technical and immunosuppressive requirements for prolonged graft survival. Plast Reconstr Surg 2009; 123: 493-501.
12. Cendales LC, Kanitakis J, Schneeberger S, et al,. The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant 2008; 8: 1396-1400. (Pubitemid 351989486)
13. Nasir S, Bozkurt M, Klimczak A, Siemionow M,. Large antigenic skin load in total abdominal wall transplants permits chimerism induction. Ann Plast Surg 2008; 61: 572-579.
14. Starzl TE, Murase N,. Microchimerism, macrochimerism, and tolerance. Clin Transplant 2000; 14: 351-354. (Pubitemid 30497140)
15. Bingaman AW, Waitze SY, Alexander DZ, et al,. Transplantation of the bone marrow microenvironment leads to hematopoietic chimerism without cytoreductive conditioning. Transplantation 2000; 69: 2491-2496. (Pubitemid 30482013)
16. Yin D, Ma L, Zeng H, Shen J, Chong AS,. Allograft tolerance induced by intact active bone co-transplantation and anti-CD40L monoclonal antibody therapy. Transplantation 2002; 74: 345-354.
17. Yin D, Dujovny N, Ma L, et al,. IFN-gamma production is specifically regulated by IL-10 in mice made tolerant with anti-CD40 ligand antibody and intact active bone. J Immunol 2003; 170: 853-860. (Pubitemid 36070538)
18. Rao SS, Peters SO, Crittenden RB, Stewart FM, Ramshaw HS, Quesenberry PJ,. Stem cell transplantation in the normal nonmyeloablated host: Relationship between cell dose, schedule, and engraftment. Exp Hematol 1997; 25: 114-121. (Pubitemid 27101325)
19. Wekerle T, Kurtz J, Ito H, et al,. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med 2000; 6: 464-469. (Pubitemid 30208167)
20. Durham MM, Bingaman AW, Adams AB, et al,. Cutting edge: Administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning. J Immunol 2000; 165: 1-4. (Pubitemid 30429481)
21. Graca L, Daley S, Fairchild PJ, Cobbold SP, Waldmann H,. Co-receptor and co-stimulation blockade for mixed chimerism and tolerance without myelosuppressive conditioning. BMC Immunol 2006; 7: 9.
22. Kean LS, Adams AB, Strobert E, et al,. Induction of chimerism in rhesus macaques through stem cell transplant and costimulation blockade-based immunosuppression. Am J Transplant 2007; 7: 320-335. (Pubitemid 46096325)
23. Kawai T, Cosimi AB, Colvin RB, et al,. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 1995; 59: 256-262.
24. Huang CA, Fuchimoto Y, Scheier-Dolberg R, Murphy MC, Neville DM, Jr,., Sachs DH,. Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model. J Clin Invest 2000; 105: 173-181. (Pubitemid 30054356)
25. Santiago SF, De FW, Khan TF, et al,. Heterotopic sternum transplant in rats: A new model of a vascularized bone marrow transplantation. Microsurgery 1999; 19: 330-334. (Pubitemid 30004183)
26. Siemionow M, Klimczak A, Unal S, Agaoglu G, Carnevale K,. Hematopoietic stem cell engraftment and seeding permits multi-lymphoid chimerism in vascularized bone marrow transplants. Am J Transplant 2008; 8: 1163-1176. (Pubitemid 351763693)
27. Kawai T, Cosimi AB, Wee SL, et al,. Effect of mixed hematopoietic chimerism on cardiac allograft survival in cynomolgus monkeys. Transplantation 2002; 73: 1757-1764. (Pubitemid 34655251)
28. Larsen CP, Page A, Linzie KH, et al,. An MHC-defined primate model reveals significant rejection of bone marrow after mixed chimerism induction despite full MHC matching. Am J Transplant 2010; 10: 2396-2409.
29. Gordon CR, Siemionow M, Papay F, et al,. The world's experience with facial transplantation: What have we learned thus far? Ann Plast Surg 2009; 63: 572-578.